Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. K.../ US3580291066 /
FMS
|
02/05/2024 18:56:41
|
Chg.
+0.20
|
Volume |
Bid18:59:40 |
Demandez à18:59:40 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
21.44USD
|
+0.94%
|
3,239
Chiffrre d'affaires: 69,467.22 |
21.42Bid taille: 100 |
21.43Ask la taille: 100 |
12.29 Mrd.USD |
- |
- |
Description de l'entreprise
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Conseil d'administration & Conseil de surveillance
| PDG |
| Helen Giza |
| Conseil d'administration |
| Martin Fischer, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, Craig Cordola |
| Conseil de surveillance |
| Michael Sen, Stefanie Balling, Sara Hennicken, Shervin J. Korangy, Dr. Marcus Kuhnert, Gregory Sorensen, M.D., Pascale Witz, Ralf Erkens, Beate Haßdenteufel, Regina Karsch, Frank Michael Prescher, Dr. Manuela Stauss-Grabo |
Données de l'entreprise
| Nom: |
Fresenius Medical Care AG & Co. KGaA |
| Adresse: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Téléphone: |
+49-6172-609-0 |
| Fax: |
+49-6172-609-2301 |
| Courriel: |
-
|
| Internet: |
www.fmc-ag.de |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
44.95% |
| IPO date: |
02/10/1996 |
Relations avec les investisseurs
| Nom: |
Dr. Dominic Heger |
| Téléphone IR: |
+49 (0) 6172 609-2525 |
| IR-Fax: |
+49 (0) 6172 609-2301 |
| E-mail IR: |
ir@fmc-ag.com
|
Calendrier de l'entreprise
|
CW 19 | 07/05/2024
Interim Report 1st Quarter/3 Months
|
|
CW 20 | 16/05/2024
General Shareholder Meeting
|
|
CW 20 | 17/05/2024
Ex-Dividend
|
|
CW 21 | 20/05/2024
Record Date
|
|
CW 21 | 22/05/2024
Dividend Payment
|
